Anlon Healthcare IPO: Files DRHP to SEBI for Upcoming IPO

Anlon Healthcare Private Limited has filed its DRHP with SEBI to prepare for its upcoming public issue. This upcoming IPO is offering entirely a fresh issue of up to 1,40,00,000 equity share.

The total aggregate size of a public issue in rupees is not disclosed, whereas the total no. of equity shares that will be issued by the company is up to 1,40,00,000 equity shares.

This IPO will follow the book-building process, with not less than 75% of the offer reserved for Qualified Institutional Buyers (QIBs), not more than 15% for Non-Institutional Investors (NIIs), and not more than 10% for retail investors is reserved.

Anlon Healthcare IPO's open date and close date is not yet declared. The price band & lot size will be revealed soon by the company. The Shares to be offered through the Red Herring Prospectus are proposed by the company to be listed on the BSE and NSE exchange.

Also Read | Midwest IPO: Files DRHP to SEBI for Upcoming IPO

About Anlon Healthcare Limited

Anlon Healthcare Limited, established on November 19, 2013, is a private company based in Rajkot, Gujarat. Specializing in the manufacturing of active pharmaceutical ingredients (APIs) and intermediates, it has gained recognition for adhering to high-quality standards and regulatory requirements from global health authorities. As of the financial year ending March 2023, Anlon reported operating revenues between INR 100 crore and 500 crores, with a remarkable 119.57% increase in EBITDA and a 453.48% rise in net worth compared to the previous year. The company is committed to innovation and customer satisfaction, positioning itself as a significant player in the pharmaceutical industry with robust R&D capabilities and a strong product pipeline.

Anlon Healthcare IPO Objectives

The company will use the net proceeds raised from the IPO fresh issue for following purposes: Capital expenditure for the expansion of its manufacturing facility which amounts to Rs 30.72 crores. Rs 5 crores will be allocated for the full or partial repayment or pre-payment of certain outstanding secured borrowings. The company will meet the working capital requirement of Rs 35.98 crores. The remaining funds will be applied toward general corporate purposes.

Financials of Anlon Healthcare Limited

The financials for the company during the period ended March 31 2024, compared to March 31 2023:

1. Assets increased from Rs 11,154.79 crores in March 2023 to Rs 12,800.08 crores in March 2024, a 14.75% increase.
2. Revenue decreased from Rs 1,128.77 crores to Rs 665.84 crores, a -41.01% negative.
3. Profit After Tax (PAT) increased from Rs 58.20 crores in March 2023 to Rs 96.57 crores in March 2024, a 65.93% increase.
4. Total Borrowing increased from Rs 663.87 crores to Rs 745.63 crores, a 12.32% increase.

Lead manager(s) and Registrar of Anlon Healthcare IPO

The IPO is managed by Interactive Financial Services Limited, which is the book-running lead manager for this public issue. The company has appointed KFin Technologies Limited as the registrar for this public issue.

Promoters of Anlon Healthcare

Punitkumar R. Rasadia, Meet Atulkumar Vachhani and Mamata Punitkumar Rasadia are the identifiable promoters (s) of the company. They collectively held 70.26% of the company's shares. However, post-IPO changes in their shareholding have not yet been disclosed in the Prospectus filed by the company with SEBI. To read full DRHP, click here.

 Also Read:

• What is IPO?
• What is IPO GMP?
• Difference between IPO and FPO For Beginners